Sage Bionetworks and Pfizer sign oncology collaboration
This article was originally published in Scrip
Executive Summary
Sage Bionetworks and Pfizer have agreed an oncology research partnership to uncover new therapeutic targets and to evaluate the safety and efficacy of development candidates.